Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: A critical factor

American Journal of Transplantation

Volumn 10, Issue 1, 2010, Pages 129-137

  Vibert, E ^a,b,c   Azoulay, D ^a,b,c   Hoti, E ^a   Iacopinelli, S ^a   Samuel, D ^a,b,c   Salloum, C ^a   Lemoine, A ^a,b,c   Bismuth, H ^a   Castaing, D ^a,b,c   Adam, R ^a,b,c  

^a HÔPITAL PAUL BROUSSE   (France)

^b Universite Paris Sud   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Cirrhosis; Hepatocellular carcinoma; Liver transplantation; Outcomes

Indexed keywords

ALPHA FETOPROTEIN; TUMOR MARKER;

ADULT; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; COMPARATIVE STUDY; DISEASE COURSE; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT INFORMATION; PATIENT SELECTION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; SALVAGE THERAPY; SATELLITE CELL; TREATMENT OUTCOME; TUMOR VOLUME;

ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; SURVIVAL RATE; TIME FACTORS;

EID: 72549115627     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02750.x     Document Type: Article

References (32)

1. El-Serag HB. Hepatocellular carcinoma: Recent trends in the United States. Gastroenterology 2004 127 (5 Suppl 1 S27 S34.
2. Llovet JM, Beaugrand M. Hepatocellular carcinoma: Present status and future prospects. J Hepatol 2003 38 (Suppl 1 S136 S149.
3. Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993 218 : 145 151. (Pubitemid 23229140)
4. Mazzaferro V, Regalia E, Doci R et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996 334 : 693 699.
5. Jonas S, Bechstein WO, Steinmuller T et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001 33 : 1080 1086.
6. Margarit C, Charco R, Hidalgo E, Allende H, Castells L, Bilbao I. Liver transplantation for malignant diseases: Selection and pattern of recurrence. World J Surg 2002 26 : 257 263.
7. Figueras J, Ibanez L, Ramos E et al. Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis: Results of a multicenter study. Liver Transpl 2001 7 : 877 883.
8. Plessier A, Codes L, Consigny Y et al. Underestimation of the influence of satellite nodules as a risk factor for post-transplantation recurrence in patients with small hepatocellular carcinoma. Liver Transpl 2004 10 (2 Suppl 1 S86 S90.
9. Parfitt JR, Marotta P, Alghamdi M et al. Recurrent hepatocellular carcinoma after transplantation: Use of a pathological score on explanted livers to predict recurrence. Liver Transpl 2007 13 : 543 551.
10. Farinati F, Marino D, De Giorgio M et al. Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: Both or neither? Am J Gastroenterol 2006 101 : 524 532.
11. Fujioka M, Nakashima Y, Nakashima O, Kojiro M. Immunohistologic study on the expressions of alpha-fetoprotein and protein induced by vitamin K absence or antagonist II in surgically resected small hepatocellular carcinoma. Hepatology 2001 34 : 1128 1134.
12. Azoulay D, Johann M, Raccuia JS, Castaing D, Bismuth H Protected" double needle biopsy technique for hepatic tumors. J Am Coll Surg 1996 183 : 160 163.
13. Bruix J, Sherman M, Llovet JM et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001 35 : 421 430.
14. Adam R, Azoulay D, Castaing D et al. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: A reasonable strategy? Ann Surg 2003 238 : 508 518 discussion 518-509
15. Majno PE, Adam R, Bismuth H et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997 226 : 688 701 discussion 701-683.
16. Belghiti J, Cortes A, Abdalla EK et al. Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg 2003 238 : 885 892 discussion 892-883.
17. Azoulay D, Samuel D, Castaing D et al. Domino liver transplants for metabolic disorders: Experience with familial amyloidotic polyneuropathy. J Am Coll Surg 1999 189 : 584 593.
18. Azoulay D, Castaing D, Adam R et al. Adult to adult living-related liver transplantation. The Paul-Brousse Hospital preliminary experience. Gastroenterol Clin Biol 2001 25 : 773 780.
19. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982 143 : 29 36.
20. Shetty K, Timmins K, Brensinger C et al. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transpl 2004 10 : 911 918.
21. Decaens T, Roudot-Thoraval F, Hadni-Bresson S et al. Impact of UCSF criteria according to pre- and post-OLT tumor features: Analysis of 479 patients listed for HCC with a short waiting time. Liver Transpl 2006 12 : 1761 1769.
22. Yao FY, Xiao L, Bass NM, Kerlan R, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: Validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant 2007 7 : 2587 2596.
23. De Carlis L, Giacomoni A, Pirotta V et al. Surgical treatment of hepatocellular cancer in the era of hepatic transplantation. J Am Coll Surg 2003 196 : 887 897.
24. Pawlik TM, Gleisner AL, Anders RA, Assumpcao L, Maley W, Choti MA. Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy. Implications for transplant eligibility. Ann Surg 2007 245 : 435 442.
25. Poon RT, Fan ST. Resection prior to liver transplantation for hepatocellular carcinoma: A strategy of optimizing the role of resection and transplantation in cirrhotic patients with preserved liver function. Liver Transpl 2004 10 : 813 815.
26. Poon RT. Optimal initial treatment for early hepatocellular carcinoma in patients with preserved liver function: Transplantation or resection? Ann Surg Oncol 2007 14 : 541 547.
27. Stuart KE, Anand AJ, Jenkins RL. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer 1996 77 : 2217 2222.
28. Yao FY, Ferrell L, Bass NM et al. Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival. Hepatology 2001 33 : 1394 1403.
29. Yamashiki N, Gaynor JJ, Kato T et al. Competing risks analysis of predictors of delisting owing to tumor progression in liver transplant candidates with hepatocellular carcinoma. Am J Transplant 2004 4 : 774 781.
30. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation. Hepatology 1999 30 : 1434 1440.
31. Collier J, Sherman M. Screening for hepatocellular carcinoma. Hepatology 1998 27 : 273 278.
32. Lesurtel M, Mullhaupt B, Pestalozzi BC, Pfammatter T, Clavien PA. Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: An evidence-based analysis. Am J Transplant 2006 6 : 2644 2650.